12/12/2018 |
Attorney Letter with Respect to Current Information |
09/30/2018 |
Active |
11/28/2018 |
Quarterly Report |
November 20, 2018 |
Active |
10/22/2018 |
Attorney Letter with Respect to Current Information |
06/30/2018 |
Active |
Oct 9, 2018 |
Quarterly Report |
Jun 30, 2018 |
Active |
July 9, 2018 |
Quarterly Report |
Mar 31, 2018 |
Active |
May 10, 2018 |
Annual Report |
Dec 31, 2017 |
Active |
Nov 27, 2017 |
Quarterly Report |
Sept 30, 2017 |
Active |
Sep 18, 2017 |
Quarterly Report |
Jun 30, 2017 |
Active |
Jul 31, 2017 |
Quarterly Report – Corrected |
Mar 31, 2017 |
Active |
Jun 13, 2017 |
Quarterly Report |
Mar 31, 2017 |
Active |
May 16, 2017 |
Notification of Late Filing |
Mar 31, 2017 |
Active |
May 3, 2017 |
Attorney Letter with Respect to Current Information – Attorney Letter |
Dec 31, 2016 |
Active |
Mar 31, 2017 |
Annual Report – OTC Pink Basic Disclosure |
Dec 31, 2016 |
Active |
Mar 31, 2017 |
Supplemental Information – Issuance History |
Dec 31, 2016 |
Active |
Mar 22, 2017 |
Quarterly Report |
Sept 30, 2016 |
Active |
Mar 13, 2017 |
Quarterly Report |
Jun 30, 2016 |
Active |
Jul 11, 2016 |
Quarterly Report |
Mar 31, 2016 |
Active |
May 8, 2015 |
OTCQB Certification |
Dec 31, 2014 |
Active |
Feb 5, 2015 |
OTCQB Certification |
Feb 5, 2015 |
Active |
Jun 17, 2014 |
Quarterly Report – Corrected |
Mar 31, 2014 |
Active |
Jun 4, 2014 |
Quarterly Report – AUDITED |
Mar 31, 2014 |
Active |
Apr 25, 2014 |
Attorney Letter with Respect to Current Information |
Dec 31, 2013 |
Active |
Apr 24, 2014 |
Annual Report |
Dec 31, 2013 |
Active |
Apr 22, 2014 |
Attorney Letter with Respect to Current Information |
Dec 31, 2013 |
Active |
Apr 18, 2014 |
Annual Report |
Dec 31, 2013 |
Active |
Apr 16, 2014 |
Annual Report |
Dec 31, 2013 |
Active |
Apr 7, 2014 |
Annual Report |
Dec 31, 2013 |
Active |
Apr 1, 2014 |
Notification of Late Filing |
Dec 31, 2013 |
Active |
Nov 14, 2013 |
Interim Financial Report – Q3 Financials |
Sept 30, 2013 |
Active |
Aug 27, 2013 |
Quarterly Report – With Audit Adjustments |
Jun 30, 2013 |
Active |
Aug 14, 2013 |
Notification of Late Filing |
Jun 30, 2013 |
Active |
May 29, 2013 |
Quarterly Report – Q1 with Disclosures |
Mar 31, 2013 |
Active |
May 23, 2013 |
Quarterly Report |
Mar 31, 2013 |
Active |
Apr 29, 2013 |
Attorney Letter with Respect to Current Information |
Dec 31, 2012 |
Active |
Apr 26, 2013 |
Annual Report |
Dec 31, 2012 |
Active |
Apr 17, 2013 |
Annual Report – Combined |
Dec 31, 2012 |
Active |
Apr 17, 2013 |
Annual Report – Annual Report Financials |
Dec 31, 2012 |
Active |
Apr 17, 2013 |
Annual Report – Annual Report Narrative |
Dec 31, 2012 |
Active |
Apr 2, 2013 |
Notification of Late Filing |
Dec 31, 2012 |
Active |
Nov 27, 2012 |
Attorney Letter with Respect to Current Information |
Sept 30, 2012 |
Active |
Nov 26, 2012 |
Quarterly Report |
Sept 30, 2012 |
Active |
Nov 20, 2012 |
Quarterly Report – Financial Statements and Disclosures Prescribed By OTC Pink Market |
Sept 30, 2012 |
Active |
Sep 25, 2012 |
Quarterly Report |
Jun 30, 2012 |
Active |
Sep 12, 2012 |
Attorney Letter with Respect to Current Information |
Jun 30, 2012 |
Active |
Sep 12, 2012 |
Quarterly Report |
Jun 30, 2012 |
Active |
Aug 14, 2012 |
Notification of Late Filing |
Jun 30, 2012 |
Active |
Jun 5, 2012 |
Attorney Letter with Respect to Current Information |
Mar 31, 2012 |
Active |
May 23, 2012 |
Quarterly Report |
Mar 31, 2012 |
Active |
May 15, 2012 |
Notification of Late Filing |
Mar 31, 2012 |
Active |
Apr 4, 2012 |
Attorney Letter with Respect to Current Information |
Dec 31, 2011 |
Active |
Apr 4, 2012 |
Annual Report – without financials |
Dec 31, 2011 |
Active |
Apr 2, 2012 |
Annual Report – Annual Financial Statements |
Dec 31, 2011 |
Active |
Nov 14, 2011 |
Attorney Letter with Respect to Current Information |
Sept 30, 2011 |
Active |
Oct 31, 2011 |
Quarterly Report |
Sept 30, 2011 |
Active |
Sep 6, 2011 |
Attorney Letter with Respect to Current Information |
Jun 30, 2011 |
Active |
Sep 1, 2011 |
Quarterly Report |
Jun 30, 2011 |
Active |